Article
Multicenter cohort study of the risk factors and mortality of Omicron variant SARS-CoV-2-infected patients with hematologic malignancies in hospitals
2023-06-26
Abstract excerpt
<h4>Purpose: </h4> Evaluating risk factors of mortality and characters in patients with hematologic malignancy (HM) after anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccination of China. Methods A total of 104 HMs were included with a median follow-up of 45 days. Results The overall mortality rate was 9.6%. In multivariable analyses, 1 or more comorbidities (P = 0.014), lactic dehydrogenase...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c74f2f41-ff53-5adb-b231-c6aab8891985
- DOI
- 10.21203/rs.3.rs-3072395/v1
